PsychRounds: The Psychiatry Podcast

Welcome Back! We have recently partnered with Psych Congress to bring our audience access to some of their leading speakers and educators, and today's episode is with Dr. Charles Raison, a psychiatrist who has done extensive research on the biological and evolutionary underpinnings of depression, which includes inflammation and the neuroendocrine system. Dr. Raison co-authored the 2017 book The Ne...

Welcome Back! We have recently partnered with Psych Congress to bring our audience access to some of their leading speakers and educators, and today is the second installment of this endeavor, featuring Dr. Jonathan Meyer on the topic of Antipsychotic plasma level monitoring. Dr. Meyer has authored the handbook on this topic, along with the Lithium and Clozapine handbooks as well. You can find the...

Welcome Back! We have recently partnered with Psych Congress to bring our audience access to some of their leading speakers and educators, and today we will be speaking to the distinguished Dr. Rakesh Jain on the topic of Positive Psychiatry. Psych Congress Discount Code: PSYCHROUNDS Conference Website: https://www.hmpglobalevents.com/psych-congress Check out Dr. Jain’s podcast “Positive Psychiatr...

Welcome back! Today we are looking at the beta-blocker Propranolol, also known by its brand name, Inderal. Although this medication is sometimes used as an anti-hypertensive, we are going to look at its use in psychiatry and anxiety disorders. Sources https://www.ncbi.nlm.nih.gov/books/NBK562942/ https://pubmed.ncbi.nlm.nih.gov/32001828/ https://pmc.ncbi.nlm.nih.gov/articles/PMC4724794/ https://pu...

On today's episode, we will be discussing Buspirone (Buspar), a commonly used medication for anxiety. References: https://www.sciencedirect.com/science/article/pii/S2405844024049491 https://pubmed.ncbi.nlm.nih.gov/3041384/ https://www.ncbi.nlm.nih.gov/books/NBK531477/ https://pubmed.ncbi.nlm.nih.gov/39493804/ https://pubmed.ncbi.nlm.nih.gov/22998742/

Today, we have one of the giants and pioneers of Asian-American Psychiatry joining us to discuss Cultural Psychiatry, Dr. Francis Lu! Dr. Lu's Books: https://www.amazon.com/stores/author/B003HFAX8E?ccs_id=d6d03eae-2c95-481f-8f7a-f844580eb108 References: https://psychiatryonline.org/doi/10.1176/appi.focus.18103 https://psycnet.apa.org/record/2015-37696-000

Welcome back! On todays episode, we will discuss hydroxyzine (Atarax, Vistaril), a frequently used medication for anxiety. References: https://pubmed.ncbi.nlm.nih.gov/9616188/ https://pubmed.ncbi.nlm.nih.gov/27998379/ https://pubmed.ncbi.nlm.nih.gov/21154375/ https://pubmed.ncbi.nlm.nih.gov/1345410/

We're back from our brief hiatus! Today, we are hosting Dr. Matthew Bernstein to talk about a rising subfield of psychiatry - Metabolic Psychiatry. We'll be looking at its history, the ketogenic diet, mitochondria, and more! References - https://pubmed.ncbi.nlm.nih.gov/38273108/ - https://pubmed.ncbi.nlm.nih.gov/34113269/ - https://pubmed.ncbi.nlm.nih.gov/39296512/ - https://pmc.ncbi.nlm.nih.gov/a...

Welcome to today's episode on the salience network, the final episode in our three-part series on neural networks. We'll explore how the salience network helps the brain prioritize what matters most by filtering relevant stimuli. References: https://pmc.ncbi.nlm.nih.gov/articles/PMC2899886/ https://www.nature.com/articles/s41398-018-0118-6 https://www.nature.com/articles/s41598-022-15489-9...

On todays episode we will be discussing Transcranial Magnetic Stimulation with a very special guest, Dr. Jonathan Downar. We will also discuss the ONE-D and THREE-D trails. Three-D Trial: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30295-2/abstract ’ One-D Trial: https://www.researchsquare.com/article/rs-5679327/v1 SAINT TMS: https://psychiatryonline.org/doi/10.1176/appi.ajp...

On today's episode, we continue our series with a discussion of the Central Executive Network, following our previous episode on the Default Mode Network. References: https://pubmed.ncbi.nlm.nih.gov/30250390/ https://pmc.ncbi.nlm.nih.gov/articles/PMC4162869/ https://link.springer.com/article/10.3758/s13415-011-0083-5 https://www.cell.com/neuron/comments/S0896-6273(06)00349-7 https://pubmed.ncbi.nl...

On today's episode we have a special international guest, Dr. Pouya Movahed Rad from Lund University in Sweden. We will be discussing Electroconvulsive therapy (ECT) and the Ket-ECT, and ELEKT-D studies. ELEKTD: https://www.nejm.org/doi/full/10.1056/NEJMoa2302399 KET-ECT: https://pubmed.ncbi.nlm.nih.gov/35020871/ Comparison: https://pubmed.ncbi.nlm.nih.gov/38114073/

Join us today as we venture into the Triple Network Model as a basis for psychiatric illness, starting with the Default Mode Network. References https://pmc.ncbi.nlm.nih.gov/articles/PMC7959111/ https://pubmed.ncbi.nlm.nih.gov/37167968/ https://www.nature.com/articles/s42003-019-0611-3 https://www.psychiatrictimes.com/view/mindwandering-mood-for-thought https://www.nature.com/articles/s41380-021-0...

Welcome back! Today we will be discussing Metformin and some of the recent guidelines published in the journal the Schizophrenia Bulletin. (Carolan et. al 2024).

On today’s special guest episode, we’ll be exploring the topic of nitrous oxide with Dr. Charles Conway and Dr. Vasilis Hristidis. https://medicine.washu.edu/news/laughing-gas-relieves-symptoms-in-people-with-treatment-resistant-depression/ https://pmc.ncbi.nlm.nih.gov/articles/PMC5825282/ https://pubmed.ncbi.nlm.nih.gov/34108247/ https://pubmed.ncbi.nlm.nih.gov/25577164/

In today’s episode, we explore ketamine’s therapeutic potential with Dr. Joshua Rosenblat, a leading expert and faculty member at the University of Toronto’s Department of Psychiatry ( learn more ). https://x.com/jd_rosenblat?lang=en https://pubmed.ncbi.nlm.nih.gov/35688035/ https://pubmed.ncbi.nlm.nih.gov/39608193/

Welcome back! Today, we are discussing a new branded medication that combines bupropion with dextromethorphan for the treatment of depression.

Today, we will be discussing tricyclic antidepressants (TCA's). Once again, we've picked a few of our favorites to discuss on today's episode.

Welcome back! Today, we will be discussing MAOIs, and we've picked out a few of our favorites for today's episode.

Could there be an evolutionary perspective for depression? Join us for part two of our series on depression and inflammation.

Join us as we talk about the relationship between depression and inflammation - an interesting biological theory.

Welcome back! Today, we have a special guest-episode with a senior medical student, Jun-Hwan Kim. Join us as we talk about anti-psychotic associated weight gain.

Today, we have a very special guest joining us—Dr. John Kane! We will be discussing his experience and history with clozapine, a groundbreaking medication for treatment-resistant schizophrenia.

Join us and we discuss a newer anti-psychotic medication, Lumateperone, brand name Caplyta.

Welcome back to our final partial agonist episode! Today we are discussing Cariprazine, brand name, Vraylar.